Description: View the full 2016 September issue of News Direct.

Description: The Mortality Improvement Survey Subcommittee of the Society's Committee on Life Insurance Mortality & Underwriting Surveys has completed its report on the results of a survey to examine mortality improvement practices with respect to life insurance pricing in both the US and Canada. A few questions were asked about functions other than pricing.

Description: This report presents results from the study undertaken during 1993 and 1994 by the Direct Response Persistency and Mortality Task Force. Direct response product experience is presented for persistency, and mortality for both underwritten and guaranteed issue products.

Description: Long-Term Care News

Description: This is the first place submission for the 2018 Student Case Study Challenge.

Description: May 2016 issue of LTC News

Description: Most actuarial explorations of increased longevity have, quite understandably, focused on its direct financial implications for things like health care costs, retirement systems, and social security or other public policy provisions. But future life extension has many other potential implications, both direct and indirect, for various socioeconomic factors, which in turn have the potential to affect the actuarial valuation of future risk contingencies. This paper examines a sampling of the socioeconomic issues emerging from the possibility of substantially increased longevity. Because of the complexity and interrelatedness of these issues, actuarial and risk modeling of this prospective environment could be a significant challenge.

Description: Long-Term Care News

Description: The purpose of this literature guide is to provide the reader with sources of information ranging, from introductory to advanced, in the areas of LTC insurance design, marketing, pricing, and valuation.

Description: The last three decades have witnessed an important rise in number of people with diabetes in Asia, especially Type 2 Diabetes. Like no other common condition, numerous innovations are currently entering the healthcare system that will soon have a significant impact on management of the condition. This presentation explores the role played by sensors/wearables, artificial intelligence, new drugs and diabetes apps. We assess the realistic potential of such advancements and give an outlook on medium-term pricing and product development.